gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NYSE · ZBHHealthcareOrthopedic & Surgical Supplies

Zimmer Biomet Holdings, Inc. (ZBH)

$110.15+13.49%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$111.27▲ 11.40% in range
Nov 3, 2025Low $79.58 · High $111.27Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Zimmer Biomet Holdings closed at $110.15 on Nov 4, up 13.49% — matching its 52-week closing high. Volume of 6.2M shares was 2.95× its 20-day average (well above normal).

Split-adjusted performance: +22.8% over one month, +33.0% over six months, +10.3% over one year.

In the quarter ended Jun 30, 2026, revenue was $2.18B, up 4.8% from a year earlier, with a net margin of 9.1%.

Short interest was 8.0M shares at the Oct 15 settlement, down 18.3% from the prior report (4.2% of float, 3.9 days to cover).

Market cap$21.01B190.7M shares
Revenue · quarter$2.18B+4.8% YoY
Diluted EPS$1.03+33.8% YoY
P/E · TTM26.0×P/S 2.5×
Net margin9.1%Gross 70.8%
Dividend yield0.87%$0.24 last paid
52-week range79.58 – 110.150.0% from high
Volume6.2M2.95× 20-day avg
Volatility · 60d38.0%Annualised
Short % of float4.2%3.9 days to cover
Net cash-$7.07BCash $410.0M
Next earnings—Not scheduled
Split-adjusted performance
1W +14.3%1M +22.8%3M +13.3%6M +33.0%YTD +22.5%1Y +10.3%3Y +6.5%5Y −24.7%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Orthopedic & Surgical Supplies

Percentile among 22 companies (100 = best)

6-month momentum85
Revenue growth32
Net margin68
Value (low P/E)71
Size86

Industry medians: 6-month return +1.5%, revenue growth +12.8%, net margin −2.8%, P/E 29.2×.

Short interest

Details →
Shares short8.0M−18.3% vs prior
Days to cover3.9Settled Oct 15
% of float4.2%
Short vol. 10d68.1%of daily volume

Closest peers by size in Orthopedic & Surgical Supplies

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
ZBHZimmer Biomet Holdings$110.15+13.49%+33.0%+4.8%9.1%26.0$21.01B
STESTERIS$247.91+7.16%+15.6%+7.3%13.4%30.0$24.17BCompare
ALGNAlign Technology$164.90+8.79%−5.2%+4.3%10.3%28.3$11.71BCompare
EWEdwards Lifesciences$99.37+4.39%+19.4%+13.6%13.9%57.0$57.28BCompare
MSAMine Safety Incorporated$177.60+2.03%+2.1%+14.5%10.9%22.6$6.85BCompare
ISRGIntuitive Surgical$482.10+9.38%+6.7%+21.7%17.1%57.6$170.32BCompare
ESTAEstablishment Labs Holdings$66.94+9.02%−10.2%+31.7%−17.4%—$1.99BCompare
ENOVEnovis$24.42+16.90%−1.7%+3.2%−0.2%—$1.41BCompare
CDRECadre Holdings$30.84−0.71%0.0%+31.8%5.5%36.6$1.32BCompare

News about Zimmer Biomet Holdings

All news →
Zimmer Biomet (ZBH) Q3 Earnings and Revenues Beat EstimatesZacks Investment Research · 19h agoNeutralZimmer Biomet Gears Up to Report Q3 Earnings: What's in the Cards?Zacks Investment Research · 6d agoNeutralShould Value Investors Buy Zimmer Biomet (ZBH) Stock?Zacks Investment Research · Oct 12, 2026▲ PositiveZimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy?Zacks Investment Research · Oct 7, 2026▲ PositiveZimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026Benzinga · May 22, 2026▲ Positive

Quick answers

What does Zimmer Biomet Holdings do?
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan.
What is ZBH's market cap?
$21.01B, based on the Nov 4 close of $110.15.
What is ZBH's P/E ratio?
26.0× trailing-twelve-month earnings of $806.70M.
Does Zimmer Biomet Holdings pay a dividend?
Yes. The latest regular dividend was $0.24 per share (ex-date Sep 30), an annualised yield of 0.87%.
How much of ZBH is sold short?
8.0M shares, 4.2% of float, as of Oct 15, 2026.
What sector is ZBH in?
Healthcare, in the Orthopedic & Surgical Supplies industry.

About Zimmer Biomet Holdings

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

HQ: Warsaw, IN17,000 employeesListed Aug 7, 2001zimmerbiomet.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology